Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET

Sponsor
Aljazeera Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02008240
Collaborator
(none)
160
1
2
33
4.9

Study Details

Study Description

Brief Summary

The aim of this randomized controlled trial is to compare the efficacy of ultrasound guided aspiration of hydrosalpingeal fluid with salpingectomy in the management patients with ultrasound visible hydrosalpinges undergoing IVF-ET.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Needle aspiration of hydrosalpinx
  • Procedure: Salpingectomy
Phase 2

Detailed Description

The adverse impact of hydrosalpinx on in vitro fertilisation embryo transfer (IVF-ET) outcomes has been confirmed by several retrospective and prospective studies .

Cochrane review of prospective randomised trials of laparoscopic salpingectomy confirmed the beneficial effect of laparoscopic salpingectomy on IVF-ET outcomes in patients with hydrosalpinges.

Surgery is not usually safe especially in patients with extensive adhesions, morbid obesity or previous multiple laparotomies. Furthermore, many infertile couples refuse to undergo bilateral salpingectomy or proximal tubal occlusion because these procedures remove any hope of spontaneous pregnancy. Other less invasive options for patients with hydrosalpinges as ultrasound-guided aspiration of hydrosalpingeal fluid, antibiotics (alone or combined with aspiration) and hysteroscopic occlusion of fallopian tube were studied in order to find an alternative to salpingectomy . Although these methods are simple and getting popular, current data are inadequate to recommend these treatment options instead of salpingectomy because most of the supporting evidences for these methods come from small retrospective studies.

A recent randomized controlled trial revealed that the aspiration of hydrosalpingeal fluid at the time of oocyte retrieval was associated with improved implantation rate and pregnancy rates.

The aim of this randomized controlled trial is to compare the efficacy of ultrasound guided aspiration of hydrosalpingeal fluid with salpingectomy in the management patients with ultrasound visible hydrosalpinges undergoing IVF-ET

Study Design

Study Type:
Interventional
Actual Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET.A Randomized Controlled Trial
Study Start Date :
Aug 1, 2011
Actual Primary Completion Date :
Feb 1, 2014
Actual Study Completion Date :
May 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Needle aspiration of hydrosalpinx

Aspiration of hydrosalpingeal fluid under ultrasound guidance

Procedure: Needle aspiration of hydrosalpinx
Under deep sedation, the retrieval of oocytes is done and then an aspiration needle is inserted into the hydrosalpinx under ultrasonographic guidance and suction is applied to aspirate the hydrosalpingeal fluid completely . If there are bilateral hydrosalpinges, the process is repeated on the opposite side.
Other Names:
  • ultrasound guidance aspiration of hydrosalpingeal fluid
  • Active Comparator: salpingectomy

    Surgical removal of hydrosalpinx

    Procedure: Salpingectomy
    laparoscopic surgical removal of affected tube is done with bipolar electrocoagulation for hemostasis. The mesosalpinx is coagulated as close a possible to the fallopian tube to avoid any compromise in the ovarian blood supply . In cases with marked adhesion, proximal ligation and a distal fenestration is done .
    Other Names:
  • surgical removal of hydrosalpinx
  • Outcome Measures

    Primary Outcome Measures

    1. The Number of Participants Who Achieved Clinical Pregnancy in a Transfer Cycle [5 weeks after embryo transfer]

    Secondary Outcome Measures

    1. The Number of Participants Who Achieved Ongoing Pregnancy in a Transfer Cycle . [18 weeks after embryo transfer]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 37 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with unilateral or bilateral hydrosalpinges visible by ultrasound

    • Age between 18 - 37 years

    • Period of infertility > 1 year

    • Body mass index between 19-29

    • Normal basal luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin concentrations.

    • Normal recent semen analysis (according to World Health Organization criteria).

    Exclusion Criteria:
    • Uterine fibroid requiring surgical removal.

    • Endometriosis.

    • Male factor of infertility requiring ICSI, Previous IVF cycles.

    • History of recurrent miscarriage.

    • Endocrinologic disorders.

    • Presence of systemic disease contraindicating pregnancy.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Aljazeera (Al Gazeera) hospital Giza Egypt

    Sponsors and Collaborators

    • Aljazeera Hospital

    Investigators

    • Study Chair: Usama M. Fouda, M.D, PhD, Assistant professor of Obstetrics and Gynecology , Faculty of medicine ,Cairo university , and scientific director of assisted conception unit, Aljazeera (Al Gazeera) hospital.
    • Study Director: Ahmed M. Sayed, M.D, PhD, Assistant professor of Obstetrics and Gynecology , Faculty of medicine ,Cairo university, and clinical director of assisted conception unit, Aljazeera (Al Gazeera) hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Prof .Usama M.Fouda, M.D , PhD, Aljazeera Hospital
    ClinicalTrials.gov Identifier:
    NCT02008240
    Other Study ID Numbers:
    • Hydrosalpinx2
    First Posted:
    Dec 11, 2013
    Last Update Posted:
    Feb 18, 2015
    Last Verified:
    Feb 1, 2015
    Keywords provided by Prof .Usama M.Fouda, M.D , PhD, Aljazeera Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 18, 2015